Neogen Corp
NEOG- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000711377
In the last 90 days, Neogen Corp insiders filed 1 open-market purchase and 0 sales; 316 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Neogen Corp as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 386
- +80 vs. Q2 2022
- Shares held
- 208.4M
- +103.6M (+98.9%) vs. Q2 2022
- Total value
- $2.91B
- +$387.2M (+15.3%) vs. Q2 2022
- New holders
- 118
- 185 more added
- Sold out
- 38
- 41 more reduced
5 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEOG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 316 | $2.13B |
| Q1 2026 | 308 | $2.16B |
| Q4 2025 | 306 | $1.56B |
| Q3 2025 | 300 | $1.36B |
| Q2 2025 | 317 | $1.15B |
| Q1 2025 | 340 | $2.37B |
| Q4 2024 | 344 | $3.15B |
| Q3 2024 | 338 | $4.27B |
| Q2 2024 | 346 | $3.93B |
| Q1 2024 | 344 | $3.78B |
| Q4 2023 | 341 | $4.66B |
| Q3 2023 | 367 | $4.12B |
| Q2 2023 | 342 | $4.99B |
| Q1 2023 | 355 | $4.12B |
| Q4 2022 | 371 | $3.30B |
| Q3 2022 | 386 | $2.91B |
| Q2 2022 | 311 | $2.52B |
| Q1 2022 | 318 | $3.15B |
| Q4 2021 | 322 | $4.54B |
| Q3 2021 | 304 | $4.32B |
| Q2 2021 | 309 | $4.60B |
| Q1 2021 | 298 | $4.43B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Neogen Corp; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Martingale Asset Management L P | 0 | $0 | 0.00% | −26,647−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −20,573−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −19,120−100.0% | Sold out |
| FDx Advisors, Inc. | 0 | $0 | 0.00% | −17,296−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −13,426−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −12,857−100.0% | Sold out |
| Sanford Advisory Services, LLC | 0 | $0 | 0.00% | −9,506−100.0% | Sold out |
| Voya Financial Advisors, Inc. | 0 | $0 | 0.00% | −9,327−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −9,322−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −9,035−100.0% | Sold out |
| Advance Capital Management, Inc. | 0 | $0 | 0.00% | −8,770−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −8,592−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −8,351−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −5,924−100.0% | Sold out |
| GW&K Investment Management, LLC | 0 | $0 | 0.00% | −1,973−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −1,192−100.0% | Sold out |
| Repertoire Partners LP | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −835−100.0% | Sold out |
| Sageworth Trust Co of South Dakota | 0 | $0 | 0.00% | −636−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −482−100.0% | Sold out |
| Curi Capital | 0 | $0 | 0.00% | −234−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| BerganKDV Wealth Management, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Icon Wealth Partners, LLC | – | – | – | – | Not filed |
| Private Capital Group, LLC | – | – | – | – | Not filed |
| HC Financial Advisors Inc | – | – | – | – | Not filed |
| Fieldpoint Private Securities, LLC | – | – | – | – | Not filed |
| Exane Derivatives | – | – | – | – | Not filed |